TPT RESOURCES
Improving patient access.
Reimbursement resources for Transitional Pass-through (TPT) payment
Effective January 1, 2025, the Centers for Medicare & Medicaid Services (CMS) approved a Transitional Pass-through (TPT) payment for Paradise® Ultrasound Renal Denervation (uRDN) for outpatient procedures. TPT provides incremental payment in addition to the applicable Ambulatory Payment Classifications (APC) payment to recognize the additional cost of Paradise uRDN. CMS also issued a distinct device category for Paradise uRDN, recognizing the highly differentiated novel and effective treatment in patients with uncontrolled hypertension.
Paradise uRDN TPT Payment Overview
- The additional TPT payment for Paradise uRDN becomes effective January 1, 2025, and is expected to remain effective for up to three years.
- TPT provides incremental payment for outpatient and ASC procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries.
- The distinct HCPCS code – C1736 Ultrasound Renal Denervation – highlights the differentiated Paradise uRDN technology and procedure.
Our reimbursement team is available to help educate your institution on TPT payments. Contact us at reimbursement@recormedical.com
Resources
The new HCPCS C-Code for the Paradise uRDN System must be reported on the hospital outpatient claim; C1736: Catheter, Renel Denervation, Ultrasound
1. 0338T (Renal Denervation, Unilateral) has a different device offset % than 0339T and potential payment is $24,258
